Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
Show full opinionHide full opinion
Hemosol (HML-T)
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
DON'T BUY
DON'T BUY
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
Show full opinionHide full opinion
Hemosol (HML-T)
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
DON'T BUY
DON'T BUY
September 20, 2002
Could run out of cash.
Show full opinionHide full opinion
Hemosol (HML-T)
September 20, 2002
Could run out of cash.
DON'T BUY
DON'T BUY
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
Show full opinionHide full opinion
Hemosol (HML-T)
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
DON'T BUY
DON'T BUY
August 19, 2002
Has cash burn and has to raise money. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
August 19, 2002
Has cash burn and has to raise money. Speculative.
DON'T BUY
DON'T BUY
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
Show full opinionHide full opinion
Hemosol (HML-T)
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
DON'T BUY
DON'T BUY
Hemosol (HML-T)
April 29, 2002
Hard to like.
DON'T BUY
DON'T BUY
April 25, 2002
Disappointed with their product results. High burn rate.
Show full opinionHide full opinion
Hemosol (HML-T)
April 25, 2002
Disappointed with their product results. High burn rate.
DON'T BUY
DON'T BUY
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
Show full opinionHide full opinion
Hemosol (HML-T)
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
DON'T BUY
DON'T BUY
April 3, 2002
Treat as a trading stock. No value right now.
Show full opinionHide full opinion
Hemosol (HML-T)
April 3, 2002
Treat as a trading stock. No value right now.
DON'T BUY
DON'T BUY
April 2, 2002
Only has one drug. Needds more diversification.
Show full opinionHide full opinion
Hemosol (HML-T)
April 2, 2002
Only has one drug. Needds more diversification.
DON'T BUY
DON'T BUY
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
Show full opinionHide full opinion
Hemosol (HML-T)
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
DON'T BUY
DON'T BUY
March 21, 2002
Too much competition.
Show full opinionHide full opinion
Hemosol (HML-T)
March 21, 2002
Too much competition.
BUY
BUY
March 20, 2002
At a good price and a good buy for an aggressive investor.
Show full opinionHide full opinion
Hemosol (HML-T)
March 20, 2002
At a good price and a good buy for an aggressive investor.
DON'T BUY
DON'T BUY
February 19, 2002
A one trick pony. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
February 19, 2002
A one trick pony. Speculative.
Showing 16 to 30 of 78 entries